Journal of Nuclear Medicine: Introduction

Journal of Nuclear Medicine

Volumn 48, Issue 1 SUPPL., 2007, Pages

  Czernin, Johannes ^a   Schelbert, Heinrich R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; EDITORIAL; GLUCOSE METABOLISM; HEAD AND NECK CARCINOMA; HUMAN; LYMPHOMA; PATIENT CARE; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; THYROID CARCINOMA;

EID: 35349017442     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (20)

1. Townsend DW, Carney JPJ, Yap JT, Hall NC. PET/ CT today and tomorrow. J Nucl Med. 2004;45(suppl):4S-14S.
2. Vogel WV, Oyen WJG, Barentsz JO, Kaanders JHAM, Corstens FHM. PET/CT: panacea, redundancy, or something in between? J Nucl Med. 2004;45:15S-24S.
3. Slomka PJ. Software approach to merging molecular with anatomic information. J Nucl Med. 2004;45(suppl):36S-45S.
4. Ratib O. PET/CT image navigation and communication. J Nucl Med. 2004;45(suppl):46S-55S.
5. Beyer T, Antoch G, Muller S, et al. Acquisition protocol considerations for combined PET/CT imaging. J Nucl Med. 2004;45(suppl):25S-35S.
6. 18F-FDG PET/CT. J Nucl Med. 2004;45(suppl):56S-65S.
7. Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med. 2004;45(suppl):66S-71S.
8. Schoder H, Larson SM, Yeung HW. PET/CT in oncology: integration into clinical management of lymphoma, melanoma, and gastrointestinal malignancies. J Nucl Med. 2004;45(suppl):72S-81S.
9. Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med. 2004;45(suppl):82S-95S.
10. Czernin J, Schelbert HR. PET/CT imaging: facts, opinions, hopes and questions. J Nucl Med. 2004;45(suppl):S1-S3.
11. Bradley JD, Perez CA, Dehdashti F, Siegel BA. Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer. J Nucl Med. 2004;45(suppl):96S-101S.
12. Beyer T, Townsend D, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379.
13. Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. J Nucl Med. 2007;48(suppl):78S-88S.
14. Schöder H, Gönen M. Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med. 2007;48(suppl):4S-18S.
15. Kasamon YL, Jones RJ, Wahl RL. Integration of PET and PET/CT into the risk-adapted therapy of lymphoma. J Nucl Med. 2007;48(suppl):19S-27S.
16. 18F-FDG PET/CT can make a difference in diagnosis and patient care. J Nucl Med. 2007;48(suppl):28S-35S.
17. Weber WA, Figlin R. Monitoring cancer treatment with PET/CT: does it make a difference? J Nucl Med. 2007;48(suppl):36S-44S.
18. Kuehl H, Veit P, Rosenbaum SJ, Bockisch A, Antoch G. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. J Nucl Med. 2007;48(suppl):45S-57S.
19. 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med. 2007;48(suppl):58S-67S.
20. Grégoire V, Haustermans K, Geets X, Roels S, Lonneux M. PET-based treatment planning in radiotherapy: a new standard? J Nucl Med. 2007;48(suppl):68S-77S.